Quick Answer
LISATA THERAPEUTICS, INC. reported Earnings Per Share Diluted of $1.91 (loss) per share for the year ending 2025.
- LISATA THERAPEUTICS, INC. showed an increase of +20.4% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from LISATA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2016 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: $0.38 (loss) per share | Q2 2020: $0.50 per share | Q3 2020: $0.29 (loss) per share | Q1 2021: $0.19 (loss) per share | Q2 2021: $0.10 (loss) per share | Q3 2021: $1.74 (loss) per share | Q1 2022: $1.05 (loss) per share | Q2 2022: $1.64 (loss) per share | Q3 2022: $7.88 (loss) per share | Q1 2023: $0.77 (loss) per share | Q2 2023: $0.50 (loss) per share | Q3 2023: $0.65 (loss) per share | Q1 2024: $0.65 (loss) per share | Q2 2024: $0.61 (loss) per share | Q3 2024: $0.59 (loss) per share | Q1 2025: $0.55 (loss) per share | Q2 2025: $0.54 (loss) per share | Q3 2025: $0.49 (loss) per share.
- Over the full 8 years of available data (2016 to 2025), LISATA THERAPEUTICS, INC.'s Earnings Per Share Diluted has grown by 61.7%.
- Historical annual values: Fiscal year 2025: $1.91 (loss) per share | Fiscal year 2024: $2.40 (loss) per share | Fiscal year 2023: $2.58 (loss) per share | Fiscal year 2022: $10.47 (loss) per share | Fiscal year 2021: $7.45 (loss) per share | Fiscal year 2020: $0.53 (loss) per share | Fiscal year 2017: $2.56 per share | Fiscal year 2016: $4.99 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: